Decentralized MDx Testing Gaining Steam but Obstacles Remain, Industry Execs Say | GenomeWeb
NEW YORK (GenomeWeb News) – Molecular diagnostic testing is making headway into decentralized settings, such as hospitals and smaller labs, despite continuing obstacles to their widespread adoption, industry executives said yesterday at the Piper Jaffray Conference held here.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.